TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/21 21:30 | 3/9/21 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Braslyn Ltd. | C5 | T | S.dm | -2,447 | 197.64 | 0 | -12 | 0 | 3,136 | D | |||||||||||||||
12/16/20 17:42 | 12/14/20 | INSG | Inseego Corp. | Electr | Comm | Communications Equipment | Braslyn Ltd. | C5 | T | S.m | -36,814 | 15.43 | 0 | -2,385 | -24 | 7,615 | D | ||||||||||||||||
10/30/20 21:53 | 10/28/20 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Braslyn Ltd. | C5 | T | S.dm | -83,334 | 208.34 | 0 | -400 | -11 | 3,136 | D | |||||||||||||||
6/16/20 19:09 | 6/12/20 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Braslyn Ltd. | C5 | T | S.ad | -58,200 | 97.00 | 0 | -600 | -16 | 3,136 | D | |||||||||||||||
6/16/20 17:03 | 6/12/20 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Braslyn Ltd. | C5 | T | S.d | -41,400 | 69.00 | 0 | -600 | -16 | 3,136 | D | |||||||||||||||
3/5/19 21:30 | 3/1/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Braslyn Ltd. | C5 | T | S.d | -18,975 | 69.00 | 0 | -275 | -8 | 3,136 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |